Ranomics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.23M

  • Investors
  • 3

Ranomics General Information

Description

Provider of drug discovery and genomics screening services intended to improve understanding of human genetics. The company's services offer variation to develop a database of rare genetic variations and health predictions based on the patient's genetic information, enabling healthcare professionals to get genetic change variation in a cost-effective and quick way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Drug Discovery
Primary Office
  • 3403 American Drive
  • Mississauga, Ontario L4V 1T4
  • Canada
+1 (416) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ranomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 02-Sep-2016 $1.23M 00.000 Completed Generating Revenue
2. Accelerator/Incubator 19-Jan-2015 0000 0000 Completed Startup
1. Seed Round 19-Jan-2015 Completed Startup
To view Ranomics’s complete valuation and funding history, request access »

Ranomics Patents

Ranomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3020548-A1 Analysis system and method for characterizing mutations at splice junctions, identification of variants at splice junctions and splicing repair agents Inactive 12-Oct-2018 000000000
CA-2944638-C Pcr-based method for generating multisite saturation mutagenic dna librairies Active 07-Oct-2016 0000000000
US-10570386-B2 Pcr-based method for generating multisite saturation mutagenic dna libraries Active 07-Oct-2016 0000000000
CA-2944638-A1 Pcr-based method for generating multisite saturation mutagenic dna librairies Active 07-Oct-2016 00000000000
US-20190382754-A1 Pcr-based method for generating multisite saturation mutagenic dna libraries Active 07-Oct-2016 C12N15/1031
To view Ranomics’s complete patent history, request access »

Ranomics Executive Team (4)

Name Title Board Seat Contact Info
Leo Wan Ph.D Co-Founder, Chief Executive Officer & Chief Scientific Officer
You’re viewing 1 of 4 executive team members. Get the full list »

Ranomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ranomics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hedgewood Asset Manager Minority 000 0000 000000 0
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
To view Ranomics’s complete investors history, request access »